1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Mean FA of a patient with vacuolating megalencephalic leukoencephalopathy and of control subjects
Region of InterestMean FAFA Decrease (%)
VML PatientControl Subjects (n = 2)
10.13 ± 0.040.14 ± 0.017.1
20.16 ± 0.010.21 ± 0.0723.8
30.26 ± 0.050.34 ± 0.0423.5
40.340.40 ± 0.0815
  • Note.—FA indicates fractional anisotropy; VML, vacuolating megalencephalic leukoencephalopathy; locations of regions of interest are depicted in Figure 4.